Results 221 to 230 of about 48,639 (314)

ANALYSIS OF HOSPITAL CHARGES AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION IN THE ERA OF MANAGED CARE1

open access: bronze, 1997
Robert J. Stratta   +3 more
openalex   +1 more source

GLIM consensus approach to diagnosis of malnutrition: A 5‐year update

open access: yesJournal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Background The Global Leadership Initiative on Malnutrition (GLIM) introduced an approach for malnutrition diagnosis in 2019 that comprised screening followed by assessment of three phenotypic criteria (weight loss, low body mass index [BMI], and low muscle mass) and two etiologic criteria (reduced food intake/assimilation and inflammation ...
Gordon L. Jensen   +42 more
wiley   +1 more source

Pancreas Transplantation Outcome Predictions-PTOP: A Risk Prediction Tool for Pancreas and Pancreas-Kidney Transplants Based on a European Cohort. [PDF]

open access: yesTransplant Direct
Miller G   +7 more
europepmc   +1 more source

Recipient age and outcome after pancreas transplantation: a retrospective dual-center analysis. [PDF]

open access: yesTranspl Int, 2021
Messner F   +10 more
europepmc   +1 more source

CLINICAL AND ECONOMIC IMPACT OF FLOW CYTOMETRY CROSSMATCHING IN PRIMARY CADAVERIC KIDNEY AND SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT RECIPIENTS1

open access: bronze, 1997
Ronald P. Pelletier   +7 more
openalex   +1 more source

The effect of elexacaftor–tezacaftor–ivacaftor on liver stiffness in children with cystic fibrosis

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Cystic fibrosis hepato‐biliary involvement (CFHBI) is a common comorbidity in patients with CF and is associated with increased morbidity and mortality. The effect of the new and highly potent CF transmembrane conductance regulator modulator therapy, elexacaftor–tezacaftor–ivacaftor (ETI), on CFHBI, is still unclear.
Stefanie Diemer   +4 more
wiley   +1 more source

EN BLOC PANCREAS AND KIDNEY TRANSPLANTATION IN A PATIENT WITH LIMITED VASCULAR ACCESS

open access: bronze, 1997
Atsushi Sugitani   +4 more
openalex   +1 more source

Comparison of progression of macrovascular diseases after kidney or pancreas and kidney transplantation in diabetic patients with end-stage renal disease [PDF]

open access: bronze, 2000
G Biesenbach   +7 more
openalex   +1 more source

Atypical hemolytic uremic syndrome: a rare complication of postendoscopic retrograde cholangiopancreatography pancreatitis

open access: yesJPGN Reports, EarlyView.
Abstract Endoscopic retrograde cholangiopancreatography (ERCP) is a crucial procedure for diagnosing and managing conditions affecting the pancreas and biliary tract. The procedure can be technically challenging and carries risks of complications, with post‐ERCP pancreatitis (PEP) being the most common.
Apoorva Nanagiri   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy